Literature DB >> 10433297

Halo sign on high resolution CT: findings in spectrum of pulmonary diseases with pathologic correlation.

Y Kim1, K S Lee, K J Jung, J Han, J S Kim, J S Suh.   

Abstract

The halo sign in a pulmonary nodule refers to the condition in which soft tissue attenuation of a pulmonary nodule is surrounded by peripheral ground glass attenuation on high resolution CT. The halo sign can be caused by several pathologic processes: hemorrhagic pulmonary nodules, tumor cell infiltration, and nonhemorrhagic inflammatory lesions. Hemorrhagic pulmonary nodules may occur in infectious diseases including invasive pulmonary aspergillosis, mucormycosis, and candidiasis and noninfectious diseases including Wegener granulomatosis and primary and metastatic hemorrhagic tumors. Tumor cell infiltration in bronchioloalveolar carcinoma, pulmonary lymphoma, and pulmonary metastatic neoplasm may appear with the halo sign. Eosinophilic lung disease and organizing pneumonia are representative of inflammatory lesions showing the sign.

Entities:  

Mesh:

Year:  1999        PMID: 10433297     DOI: 10.1097/00004728-199907000-00025

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  10 in total

Review 1.  Imaging of community-acquired pneumonia: Roles of imaging examinations, imaging diagnosis of specific pathogens and discrimination from noninfectious diseases.

Authors:  Atsushi Nambu; Katsura Ozawa; Noriko Kobayashi; Masao Tago
Journal:  World J Radiol       Date:  2014-10-28

Review 2.  Recent developments in the management of invasive fungal infections in patients with oncohematological diseases.

Authors:  Markus Ruhnke; Stefan Schwartz
Journal:  Ther Adv Hematol       Date:  2016-07-01

Review 3.  The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts.

Authors:  Sarah P Georgiadou; Nikolaos V Sipsas; Edith M Marom; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

Review 4.  The incidental pulmonary nodule in a child. Part 1: recommendations from the SPR Thoracic Imaging Committee regarding characterization, significance and follow-up.

Authors:  Sjirk J Westra; Alan S Brody; Maryam Ghadimi Mahani; R Paul Guillerman; Shilpa V Hegde; Ramesh S Iyer; Edward Y Lee; Beverley Newman; Daniel J Podberesky; Paul G Thacker
Journal:  Pediatr Radiol       Date:  2015-02-06

5.  Gastric and pulmonary lymphoma presenting as a solitary pulmonary nodule.

Authors:  El Thomas; Np Lenzo; R Troedson
Journal:  Biomed Imaging Interv J       Date:  2007-10-01

6.  Multiple pulmonary metastases with halo-sign from malignant mixed Müllerian tumors.

Authors:  Hong-Wei Tian; Wei-Bing Yang; Meng-Jie Yang; Jing-Yuan Liu; Jian-Chu Zhang; Xiao-Nan Tao; Qiong Zhou
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

7.  Thoracic endometriosis with catamenial haemoptysis and pneumothorax: computed tomography findings and long-term follow-up after danazol treatment.

Authors:  Thitiporn Suwatanapongched; Viboon Boonsarngsuk; Naparat Amornputtisathaporn; Paisan Leelachaikul
Journal:  Singapore Med J       Date:  2015-07       Impact factor: 1.858

8.  Septic pulmonary embolism caused by a Klebsiella pneumoniae liver abscess: clinical characteristics, imaging findings, and clinical courses.

Authors:  Deng-Wei Chou; Shu-Ling Wu; Kuo-Mou Chung; Shu-Chen Han
Journal:  Clinics (Sao Paulo)       Date:  2015-06-01       Impact factor: 2.365

9.  The halo sign: HRCT findings in 85 patients.

Authors:  Giordano Rafael Tronco Alves; Edson Marchiori; Klaus Irion; Carlos Schuler Nin; Guilherme Watte; Alessandro Comarú Pasqualotto; Luiz Carlos Severo; Bruno Hochhegger
Journal:  J Bras Pneumol       Date:  2016 Nov-Dec       Impact factor: 2.624

10.  Clinical features of acute fibrinous and organizing pneumonia: An early histologic pattern of various acute inflammatory lung diseases.

Authors:  Yasutaka Onishi; Tetsuji Kawamura; Takanori Higashino; Rokuro Mimura; Hiroaki Tsukamoto; Shin Sasaki
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.